Hjem › Endometriekreft › Wisconsin
Kliniske studier for Endometriekreft i Wisconsin
24 studier for Endometriekreft søker deltakere på steder i Wisconsin.
Byer i Wisconsin
Offisiell studietekst (engelsk)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- og 42 flere
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
- Medical College of Wisconsin, Milwaukee
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 2. okt. 2026 · NCT05950464The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Duluth Clinic Ashland, Ashland
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
- og 8 flere
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 2. okt. 2026 · NCT07198074A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Mayo Clinic Health System - Northwest Wisconsin, Eau Claire
- Mayo Clinic Health System - Southwest Wisconsin, La Crosse
RekruttererObservasjonsstudie
Alder 18 og eldre · Kvinner · Oppdatert 29. sep. 2026 · NCT05051722Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 28. sep. 2026 · NCT05112601Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Milwaukee
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06218914Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- Medical College of Wisconsin, Milwaukee
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 24. sep. 2026 · NCT05640999Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Madison
RekruttererFase 2
Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05489211A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Froedtert & MCW Cancer Center, Milwaukee
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07109726ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Madison
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 3. sep. 2026 · NCT06989112A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Froedtert and Medical College of Wisconsin, Milwaukee
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 21. aug. 2026 · NCT05548296Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Froedtert Hospital, Milwaukee
Rekrutterer
Alder 65 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07227077FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Wisconsin, Carbone Cancer Center, Madison
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- University of Wisconsin- Madison, Madison
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Waukesha
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 29. jul. 2026 · NCT07044336Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 121, Milwaukee
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 16. jul. 2026 · NCT06906341Study of EV for Recurrent Endometrial Carcinoma
- Froedtert Memorial Lutheran Hospital, Milwaukee
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 13. jul. 2026 · NCT07139977Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- Wisconsin Institute Medical Research- UW Cancer Connect, Madison
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 2. jun. 2026 · NCT06730347A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Froedtert & the Medical College of Wisconsin, Milwaukee
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 4. nov. 2025 · NCT05902988SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.